each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
On July 1, 2026, Karen Ferrante, M.D. provided notice to the board of directors (the “Board”) of MacroGenics, Inc. (the “Company”) of her decision to resign from the Board, effective September 1, 2026.
Effective July 7, 2026, John Williams, Jr., a member of the Board of Directors (the “Board”) of Old Second Bancorp, Inc. (the “Company”), resigned from the Board.
On June 30, 2026, Renger van den Heuvel, Crisp Momentum Inc.’s (the “Company”) Chief Executive Officer, principal financial officer, principal accounting officer, and a member of the Company’s Board of Directors (the “Board”), resigned from his officer and director positions with the Company.
On July 2, 2026, Chris Sambar, the Chief Operating Officer of Public Storage (the “Company”), resigned effective at the end of July to join T-Mobile as Chief Enterprise Officer.
On June 30, 2026, Steven Dassing resigned from his position as Vice President, Corporate Controller and Principal Accounting Officer of Quaker Chemical Corporation (“Quaker Houghton” or the “Company”) effective July 22, 2026.
After over two decades in various leadership positions with the Company, Michael J. Katz, the Company’s Chief Business and Product Officer, has decided to step away from his position at the Company effective July 8, 2026, but he will remain with the Company as a strategic advisor through December 2026.
On July 2, 2026, Jeffrey Rhodes notified the LifeStance Health Group, Inc. (the “Company”) board of directors (the “Board”) of his resignation from the Board and all of its committees, effective immediately.
Departed
Stephen Markscheid
Director
Four Leaf Acquisition Corp
Effective
2026-07-07
Filed
July 7, 2026, 4:15 PM ET
Effective July 7, 2026, the following directors resigned from the Board of Directors (the “Board”) of Four Leaf Acquisition Corporation (the “Company”): ● Alvin Wang ● Stephen Markscheid ● Rahul Mewawalla
Departed
Alvin Wang
Director
Four Leaf Acquisition Corp
Effective
2026-07-07
Filed
July 7, 2026, 4:15 PM ET
Effective July 7, 2026, the following directors resigned from the Board of Directors (the “Board”) of Four Leaf Acquisition Corporation (the “Company”): ● Alvin Wang ● Stephen Markscheid ● Rahul Mewawalla
Departed
Coco Kou
Chief Financial Officer
Four Leaf Acquisition Corp
Effective
2026-07-07
Filed
July 7, 2026, 4:15 PM ET
Effective July 7, 2026, Ms. Coco Kou, Chief Financial Officer of the Company resigned from her position with the Company, effective immediately.
Departed
Rahul Mewawalla
Director
Four Leaf Acquisition Corp
Effective
2026-07-07
Filed
July 7, 2026, 4:15 PM ET
Effective July 7, 2026, the following directors resigned from the Board of Directors (the “Board”) of Four Leaf Acquisition Corporation (the “Company”): ● Alvin Wang ● Stephen Markscheid ● Rahul Mewawalla
On July 2, 2026, Carson Heagen, the Chief Operating Officer of Expion360 Inc. (the “Company”), notified the board of directors of the Company that he is resigning from his role as Chief Operating Officer, effective August 1, 2026, due to personal reasons.
On July 6, 2026, Shawn Morris resigned from his position as a member of the Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) and as a member of the Compliance Committee of the Board, effective immediately.
On July 6, 2026, Andrew Levin, M.D., Ph.D., a member of the Board of Directors (the “Board”) of Vor Biopharma Inc. (the “Company”), delivered his notice of resignation, effective immediately.
On June 30, 2026, Michael D. Hill, Chief Financial Officer of Upland Software, Inc. (the “Company”) notified the board of directors of the Company (the “Board”) of his intention to retire as Chief Financial Officer, effective July 27, 2026 (the “Effective Date”).
Departed
Lori M. Toomey
Director
Kingfish Holding Corp
Filed
July 7, 2026, 12:01 PM ET
Lori M. Toomey, a member of the Board of Directors (the “Board”) of Kingfish Holding Corporation (the “Company”), has advised the Company on June 30, 2026, that she has determined not to stand for re-election at the Company’s 2027 annual meeting of shareholders.
Departed
Brian Douglas
Chief Executive Officer
GRAHAM ALTERNATIVE INVESTMENT FUND I LLC
Effective
2026-06-26
Filed
July 7, 2026, 9:57 AM ET
Eff e cti v e June 26 , 2026, Brian Douglas , previously the Chief Executive Officer of Graham Capital Management , L.P., the manag e r (the "Manager") of Graham Alternative Investment Fund I LLC (the "Company"), retired from his role at the Manager.
Departed
Brian Douglas
Chief Executive Officer
GRAHAM ALTERNATIVE INVESTMENT FUND II LLC
Effective
2026-06-26
Filed
July 7, 2026, 9:56 AM ET
Effective June 26, 2026, Brian Douglas, previously the Chief Executive Officer of Graham Capital Management, L.P., the manager (the "Manager") of Graham Alternative Investment Fund II LLC (the "Company"), retired from his role at the Manager.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
In connection with the Merger, effective as of the Effective Time, John P. Bilbrey, Amanda Baldwin, Christine Dagousset, Pamela Edwards, Deirdre Findlay, Tricia Glynn, Jerome Griffith, Martha Morfitt, David Mussafer, Emily White and Michael White ceased to be members of the Company’s board of directors or any committee thereof.
Departed
Hamid Akhavan
Chief Executive Officer, EchoStar Capital, President and Chief Executive Officer, Hughes and board member
Hughes Satellite Systems Corp
Effective
2026-07-06
Successor
Charles W. Ergen
Filed
July 7, 2026, 9:01 AM ET
Mr. Hamid Akhavan, Chief Executive Officer, EchoStar Capital, President and Chief Executive Officer Hughes (as defined below) and a member of EchoStar Corporation’s (“EchoStar” or the “Company”) and Hughes Satellite Systems Corporation (“Hughes”) boards of directors, notified the Company and Hughes that he will resign effective immediately from all positions with the Company and Hughes.
Aitan Zacharin resigned from all officer positions effective immediately upon such appointment and agreed to remain as a member of the Board of Directors solely until the expiration of the ten (10) day period required under Rule 14f-1.
Upon expiration of such period, Mr. Zacharin’s resignation as a director will become effective and Mr. Sanchez Talavera will remain as the sole director of the Company.
On July 3, 2026, Morana Jovan-Embiricos, Ph.D., notified Kalaris Therapeutics, Inc. (the “Company”) of her decision to resign as a member of the Company’s board of directors (the “Board”), effective immediately.
On July 1, 2026, Steven Kemps notified S&P Global Inc. (the “Company”) of his decision to retire from his role as Executive Vice President, Chief Legal Officer, effective December 31, 2026
Mr. Matthew R. Fuchsen resigned from his position as the Company’s Chief Development Officer, to serve as Chief Strategy Officer of Midera.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.